Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Special Reports
Special Reports
The top 10 biopharma M&A deals of 2022
Analysts expected a surge of M&A last year, but it didn't quite pan out.
Eric Sagonowsky
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Angus Liu
,
Zoey Becker
Jan 30, 2023 3:00am
2022 drug approvals: Biopharma delivered 37 new drugs
Jan 3, 2023 3:00am
2022's Fiercest Women in Life Sciences
Nov 14, 2022 3:00am
The most productive biopharma workforces of 2021
Sep 26, 2022 3:00am
The most damning FDA rebukes of the COVID-19 era
Aug 8, 2022 3:00am
The top 10 Big Pharmas for diversity, equity and inclusion in 2022
Aug 1, 2022 3:00am
